Previous studies have described raised levels of proinflammatory cytokines, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and IL-1β, in GBS patients (51, –, 54) and demonstrated their contribution to the symptoms of the disease (55, 56). This evidence concerns the gene TNF and Guillain-Barre syndrome.